Supported by our scientific and technical expertise, we provide services to meet clinical needs for personalized medicine. At the crossroads between industry and research, our team shows a unique savoir-faire.
Our solutions are based on a clever mix of:
The mission of our R&D unit is to innovate, develop and create new tests in order to propose new solutions adapted to each patient. We collaborate with research laboratories, in particular the INSERM UMR 1296 academic laboratory “Radiation: defense, health, environment”, directed by Dr Nicolas Foray, in Lyon, to carry out our developments.
Our R&D unit focuses on:
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S
Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity.
CANCERS (BASEL). 2021 MAY 19;13(10):2477. DOI: 10.3390/CANCERS13102477. PMID: 34069662; PMCID: PMC8160794. Deneuve S, Bastogne T, Duclos M, Mirjolet C, Bois P, Bachmann P, Nokovitch L, Roux PE, Girodet D, Poupart M, Zrounba P, Claude L, Ferella L, Iacovelli NA, Foray N, Rancati T, Pereira S